Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Inflammatory Bowel Disease, including ulcerative colitis, is thought to result from an
imbalance of pro-inflammatory and anti-inflammatory factors. As such, the majority of
treatment options are directed at attempting to control the chronic inflammation and
prolonging remission of clinical symptoms. Several studies have proven that curcumin has
well-established anti-inflammatory properties. However, curcumin has poor bioavailability and
prior studies have needed to use high concentrations in order to study the efficacy of the
product. The investigators propose that a bio-enhanced preparation of curcumin will require a
lower dosage to reach and affect its target tissue and will subsequently produce less adverse
side effects.